We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Postsurgery Distress in Children Eased by Hormone Treatment

By HospiMedica International staff writers
Posted on 14 Jul 2009
Oral treatment with melatonin in children before undergoing surgery can significantly reduce the occurrence of emergence delirium, according to a new study. More...


Researchers at the University of California Irvine (USC; USA) examined a study group that consisted of 148 subjects between the ages of two and eight undergoing outpatient surgery under general anesthesia. The children were randomly assigned to receive either midazolam (the recommended premedication for anxiety reduction in children scheduled for surgery) or melatonin orally before surgery. The children were followed throughout their surgical experience as researchers measured anxiety and secondary study outcomes of anesthesia administration compliance and emergence behavior. Behaviors were measured using the Yale preoperative anxiety scale (mYPass), the Induction Compliance Checklist, and the Keegan scale.

The researchers found that preoperative melatonin administration did not effectively reduce anxiety levels; however, it was found that melatonin did demonstrate a direct dose dependent effect on emergence delirium. Children in the melatonin premedication group received any of three doses of melatonin: 0.05 mg/kg, 0.2 mg/kg and 0.4 mg/kg, while the incidence of delirium at each dose was 25%, 8.3%, and 5.4%, respectively. The study was published in the July 2009 issue of Anesthesiology.

"Studies conducted in adults have revealed that oral administration of melatonin before surgery beneficially reduced anxiety levels, but relevant similar treatment data for children undergoing anesthesia and surgery are limited,” said lead author Zeev Kain, M.D., MBA, of the department of anesthesiology. "It was found that melatonin significantly reduced the incidence of emergence delirium in these children. As 3 million children undergo surgery in the U.S. each year, these findings reveal noteworthy health care and treatment implications.”

Emergence delirium is a distressing incidence of acute behavioral changes experienced when emerging from general anesthesia, and affects up to 20% of children who undergo surgery. Acute behavioral changes in the postanesthesia care unit (PACU) include crying, thrashing, and need for restraint. The condition can also lead to the development of behavioral changes outside the recovery suite, with the onset of nightmares, bed wetting, and separation anxiety.

Related Links:

University of California Irvine



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.